Analyst Ratings for Quince Therapeutics Inc. (QNCX)
QNCX Rating Summary
QNCX Price Target Summary
- Highest: $82.00 (Oppenheimer)
- Lowest: $4.00 (Leerink)
- Average: $56.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$56.00 (+74.4%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$56.00 (+74.4%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Craig-Hallum | Albert Lowe | New Coverage | Buy (N/A) |
68.00 (N/A) |
34.57 (32.11) |
-7.12% | Details |
| 7/29/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
82.00 (N/A) |
19.37 (32.11) |
65.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
